Topic 420 integrated platform for in-depth single-cell proteomics period of performance september 13, 2021-june 12, 2022 FY21 phase i sbir
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91021C00015
- Awardee
-
Micromics Technologies LLC UEI D5MRMU9JKMQ4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $455,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · PHS20211 · Posted Jul 9, 2020
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Solicitation · Posted Jul 28, 2020
- Contract value 100% obligated
- $455,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Mapleton, UT 84664, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $55,000 | |
| Other Administrative Action | $0 | |
| Original award | $400,000 |
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Micromics Technologies LLC for the development of an "Integrated Platform for In-Depth Single-Cell Proteomics". The contract has a performance period from September 13, 2021 to June 12, 2022 and a ceiling value of $455,000. It is a firm fixed-price definitive contract set aside for small businesses. The original contract opportunity was a pre-solicitation notice under the SBIR program, seeking proposals for innovative research to address NIH and CDC mission needs across various biomedical and public health topics.
Quick answers
Who was awarded contract 75N91021C00015?
75N91021C00015 was awarded to Micromics Technologies LLC by National Cancer Institute (National Institutes of Health) on September 13, 2021.
How much is contract 75N91021C00015 worth?
The government has obligated $455,000 on 75N91021C00015.
Was contract 75N91021C00015 competed?
The extent of competition for 75N91021C00015 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award